The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2019
Filed:
Apr. 20, 2016
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, Middlesex, GB;
Inventors:
John David Harling, Stevenage, GB;
Ian Edward David Smith, Stevenage, GB;
Assignee:
GlaxoSmithKline Intellectual Property Development Limited, Brentford, Middlesex, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/14 (2006.01); A61K 31/4725 (2006.01); A61K 31/519 (2006.01); C07D 417/12 (2006.01); C07D 487/04 (2006.01); A61K 47/54 (2017.01); A61K 47/66 (2017.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/4725 (2013.01); A61K 31/519 (2013.01); A61K 47/545 (2017.08); A61K 47/66 (2017.08); C07D 417/12 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of RIP2 kinase, including degrading RIP2 kinase, the treatment of diseases and conditions mediated by the RIP2 kinase, in particular for the treatment of inflammatory diseases or conditions.